Remove Immunity Remove Labelling Remove Research Laboratories
article thumbnail

Merck acquires Prometheus Biosciences

Express Pharma

Prometheus is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialisation of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases. The acquisition is subject to Prometheus Biosciences shareholder approval.